Cambridge, UK
July 02, 2018
:
TTP Plc (TTP), a leading independent technology and product development company, and Cubed Laboratories (Cubed), a developer of rapid, DNA-based molecular diagnostic devices and test kits, announced the successful completion
Burlington and Amsterdam
July 02, 2018
:
LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, and Royal Philips, a global leader in health technology, announced a collaboration to further advance digital pathology.
London
June 28, 2018
:
Oxford BioDynamics Plc , a biotechnology company focused on the discovery and development of epigenetic biomarkers based on regulatory genome architecture, for use within the pharmaceutical and biotechnology
Lake Zurich
June 27, 2018
:
Zetta Medical Technologies announces the release of its latest MRI software algorithm for image quality enhancement and image optimization of short scanning techniques.
Seattle
June 22, 2018
:
PATH announced a new partnership with south Korean company SD Biosensor to support the development and availability in key markets of a new diagnostic intended to support malaria elimination efforts. PATH and
Strasbourg, France
June 18, 2018
:
Emosis, a medical device company specialising in cytomolecular diagnostics of hemostasis disorders, and 5-Diagnostics (5-D), a worldwide distributor for haemostasis products and in-vitro diagnostics (IVD), have signed an exclusive distribution agreement.
Cambridge
June 14, 2018
:
Akcea Therapeutics, Inc, an affiliate of Ionis Pharmaceuticals, Inc., and Ambry Genetics Corporation, a Konica Minolta company, has announced the launch of hATTR Compass, a no-cost, confidential genetic testing and
Our Bureau, Mumbai
June 14, 2018
:
On ‘World Blood Donor Day’, country’s in-vitro diagnostics (IVD) market leader Roche Diagnostics India is propagating and encouraging the use of NAT Polymerase Chain Reaction (PCR) tested blood to contain
Santa Clara, USA
June 14, 2018
:
Agilent Technologies Inc announced that the US Food and Drug Administration (FDA) has approved its Dako PD-L1 IHC 22C3 pharmDx assay for expanded use.
Our Bureau, Mumbai
June 06, 2018
:
Metropolis Healthcare has launched sFlt-1/PlGF ratio, a new tool for the diagnosis of preeclampsia by discriminating between preeclamptic pregnancies and other forms of pregnancy-related hypertensive disorders.